March 14th, 2018. Our AKR1C3 related research move a step forward!!!! The manuscript titled" Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid" is in press on EJMC
April 6th, 2018 - Alessandro "Girri" Giraudo will defend his Double Degree PhD (UniTO - University of Copenhagen, DK) titled: Development of GABA-A receptor ligands using a bioisosteric approach. Tutors dr. Marco L.Lolli and prof Bente Frolund.
February 2018 - The project nicknamed NACTUS, supported by Fondazione CRT and dedicated to target AKR1C3 inside prostate cancer, officially start.
: scientific collaborations
: funders and supporters.